RDGL Stock Chart & Stats
$0.07
$0.00(0.00%)
At close: 4:00 PM EST
$0.07
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.04 - $0.14
Previous CloseN/A
Volume743.38K
Average Volume (3M)804.85K
Market Cap
$29.31M
Enterprise Value$30.67M
Total Cash (Recent Filing)$2.53M
Total Debt (Recent Filing)$109.59K
Price to Earnings (P/E)―
Beta0.89
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding493,890,600
10 Day Avg. Volume689,457
30 Day Avg. Volume804,846
Financial Highlights & Ratios
PEG Ratio2.40
Price to Book (P/B)18.78
Price to Sales (P/S)456.17
P/FCF Ratio-14.43
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue394.79
Enterprise Value/Gross Profit-143.26
Enterprise Value/Ebitda-10.81
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Vivos News
RDGL FAQ
What was Vivos Inc’s price range in the past 12 months?
Vivos Inc lowest stock price was $0.04 and its highest was $0.14 in the past 12 months.
What is Vivos Inc’s market cap?
Vivos Inc’s market cap is $29.31M.
When is Vivos Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vivos Inc’s earnings last quarter?
Currently, no data Available
Is Vivos Inc overvalued?
According to Wall Street analysts Vivos Inc’s price is currently Overvalued.
Does Vivos Inc pay dividends?
Vivos Inc does not currently pay dividends.
What is Vivos Inc’s EPS estimate?
Vivos Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vivos Inc have?
Vivos Inc has 493,890,600 shares outstanding.
What happened to Vivos Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vivos Inc?
Currently, no hedge funds are holding shares in RDGL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vivos Inc
Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an injectable particle-gel that utilizes yttrium-90 for targeted radiation treatment of cancerous growths in both humans and animals. Additionally, the company provides IsoPet, a specific treatment for solid tumors found in animals. Established in 1994, Vivos Inc. is based in Richland, Washington. It previously operated under the name Advanced Medical Isotope Corporation before rebranding to Vivos Inc. in December 2017.